Browsing Harvard Medical School by Keyword "chemotherapeutic target"
Now showing items 1-1 of 1
-
The REST Gene Signature Predicts Drug Sensitivity in Neuroblastoma Cell Lines and Is Significantly Associated with Neuroblastoma Tumor Stage
(MDPI, 2014)Neuroblastoma is the most common and deadly solid tumor in children, and there is currently no effective treatment available for neuroblastoma patients. The repressor element-1 silencing transcription (REST) factor has ...